中国女人和老外的毛片_少妇激情作爱视频_成人无码区免费AⅤ片在线观看_国产freeXXXX性播放_欧美人与性囗牲恔配的起源

首頁 > 產(chǎn)品目錄 > 信號通路 > Protein Tyrosine Kinase/RTK > VEGFR > 尼達(dá)尼布乙磺酸鹽

尼達(dá)尼布乙磺酸鹽

ChemLeader 99+%

Nintedanib Ethanesulfonate Salt | Intedanib | BIBF 1120

產(chǎn)品編號：CL1034A CAS No.：656247-18-6 MDLNo： 分子式：C31H33N5O4.C2H6O3S 分子量：649.76 | 539.64(free)
規(guī)格 庫存 目錄價(jià) 會員專享價(jià) 數(shù)量
10 mg In-stock ￥300.00 登錄后可見
- +
25 mg In-stock ￥500.00 登錄后可見
- +
50 mg In-stock ￥900.00 登錄后可見
- +
100 mg In-stock ￥1300.00 登錄后可見
- +

化學(xué)品安全說明書(MSDS)

下載MSDS

質(zhì)檢證書(COA)

  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻(xiàn)
基本信息
英文名稱 Nintedanib Ethanesulfonate Salt | Intedanib | BIBF 1120
中文名稱尼達(dá)尼布乙磺酸鹽
CAS號656247-18-6
分子式C31H33N5O4.C2H6O3S
分子量649.76 | 539.64(free)
外觀Yellow powder
儲存條件4°C, sealed storage, away from moisture
產(chǎn)品詳情

BIBF 1120 is an inhibitor of the receptor tyrosine kinases VEGFR, FGFR, and PDGFR (IC50s = 13-34, 37-610, 59, and 65 nM for VEGFR1-3, FGFR1-4, PDGFRα, and PDGFRβ, respectively).1 It is selective for VEGFR, FGFR, and PDGFR over a panel of 33 kinases but does inhibit FLT3, LCK, LYN, and Src (IC50s = 16-156 nM). BIBF 1120 inhibits growth factor-dependent proliferation of human umbilical vascular endothelial cells (HUVECs), human microvascular skin endothelial cells (HSMECs), human umbilical artery smooth muscle cells (HUASMCs), and bovine retinal pericytes (BRPs; EC50s = 7-290 nM). In vivo, BIBF 1120 (100 mg/kg) reduces tumor microvessel density and the number of PDGFRβ-expressing perivascular cells in a FaDu head and neck small cell carcinoma mouse xenograft model. It also inhibits tumor growth in a Caki-1 renal cancer mouse xenograft model. Formulations containing BIBF 1120 have been used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer (NSCLC).



相關(guān)文獻(xiàn)
抱歉，暫時(shí)沒有相關(guān)文獻(xiàn)
在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時(shí)間: 工作日 9:00-18:00